BR112023025095A2 - Variantes de capsídeo e métodos para usar as mesmas - Google Patents
Variantes de capsídeo e métodos para usar as mesmasInfo
- Publication number
- BR112023025095A2 BR112023025095A2 BR112023025095A BR112023025095A BR112023025095A2 BR 112023025095 A2 BR112023025095 A2 BR 112023025095A2 BR 112023025095 A BR112023025095 A BR 112023025095A BR 112023025095 A BR112023025095 A BR 112023025095A BR 112023025095 A2 BR112023025095 A2 BR 112023025095A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- capsid
- viral particles
- dependentoparvovirus
- capsid variants
- Prior art date
Links
- 210000000234 capsid Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 230000003612 virological effect Effects 0.000 abstract 3
- 108090000565 Capsid Proteins Proteins 0.000 abstract 2
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000026683 transduction Effects 0.000 abstract 1
- 238000010361 transduction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14145—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
variantes de capsídeo e métodos para usar as mesmas. a divulgação é dirigida em parte a polipeptídeos de capsídeo variantes que podem ser usados para distribuir cargas úteis. a presente divulgação fornece, em parte, proteínas de capsídeo de dependoparvovírus variantes melhoradas (por exemplo, aav2), tal como vp1, métodos de produção de um dependoparvovírus, composições para uso nas mesmas, bem como partículas virais produzidas pelas mesmas. em algumas modalidades, as partículas virais que são produzidas têm transdução ocular aumentada em comparação com partículas virais sem as mutações nas proteínas de capsídeo.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196554P | 2021-06-03 | 2021-06-03 | |
| US202263331627P | 2022-04-15 | 2022-04-15 | |
| US202263342455P | 2022-05-16 | 2022-05-16 | |
| PCT/US2022/032004 WO2022256557A1 (en) | 2021-06-03 | 2022-06-02 | Capsid variants and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025095A2 true BR112023025095A2 (pt) | 2024-02-20 |
Family
ID=84324583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025095A BR112023025095A2 (pt) | 2021-06-03 | 2022-06-02 | Variantes de capsídeo e métodos para usar as mesmas |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4347621A1 (pt) |
| JP (1) | JP2024520738A (pt) |
| KR (1) | KR20240045198A (pt) |
| AU (1) | AU2022284870A1 (pt) |
| BR (1) | BR112023025095A2 (pt) |
| IL (1) | IL308987A (pt) |
| WO (1) | WO2022256557A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023201364A2 (en) * | 2022-04-15 | 2023-10-19 | Dyno Therapeutics, Inc. | Capsid variants and methods of using the same |
| WO2024059667A2 (en) * | 2022-09-13 | 2024-03-21 | Dyno Therapeutics, Inc. | Capsid variants and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101460611B (zh) * | 2006-06-08 | 2013-04-24 | 巴斯福植物科学有限公司 | 具有改良生长特性的植物及其制备方法 |
| WO2011119484A1 (en) * | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| RU2770922C2 (ru) * | 2017-09-20 | 2022-04-25 | 4Д Молекьюлар Терапьютикс Инк. | Капсиды вариантов аденоассоциированных вирусов и методы их применения |
-
2022
- 2022-06-02 KR KR1020247000005A patent/KR20240045198A/ko unknown
- 2022-06-02 JP JP2023574862A patent/JP2024520738A/ja active Pending
- 2022-06-02 WO PCT/US2022/032004 patent/WO2022256557A1/en active Application Filing
- 2022-06-02 AU AU2022284870A patent/AU2022284870A1/en active Pending
- 2022-06-02 BR BR112023025095A patent/BR112023025095A2/pt unknown
- 2022-06-02 EP EP22816871.2A patent/EP4347621A1/en active Pending
- 2022-06-02 IL IL308987A patent/IL308987A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240045198A (ko) | 2024-04-05 |
| EP4347621A1 (en) | 2024-04-10 |
| IL308987A (en) | 2024-01-01 |
| JP2024520738A (ja) | 2024-05-24 |
| AU2022284870A1 (en) | 2024-01-04 |
| WO2022256557A1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023025095A2 (pt) | Variantes de capsídeo e métodos para usar as mesmas | |
| BR112021019821A2 (pt) | Sorotipo de vírus adenoassociado híbrido recombinante com modificação peptídica entre aav9 e aavrh74 com tropismo hepático reduzido e transdução muscular aumentada | |
| MX2018012663A (es) | Metodos para aumentar la capacidad de actividad biológica del virus adenoasociado recombinante producido mediante el sistema baculovirus. | |
| CO2020005645A2 (es) | Proteínas trispecificas y métodos de uso | |
| CO2017011344A2 (es) | Producción de vectores adeno-asociados de gran tamaño | |
| CO2020004738A2 (es) | Variantes de cápsides de virus adenoasociados y métodos de uso de estas | |
| MX2020006117A (es) | Integracion dirigida de acidos nucleicos. | |
| BR112018074463A2 (pt) | anticorpos anti-tim-3 e métodos de uso dos mesmos. | |
| BR112018068189A2 (pt) | proteínas de ligação induzíveis e métodos de uso | |
| EA201990715A1 (ru) | Стабилизирующие тример мутации белка оболочки hiv | |
| EA201891415A1 (ru) | Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения | |
| BR112014024612A2 (pt) | ácido nucleico, polipeptídeo, glicoproteína e quimérica, epítopo de vírus da dengue, partícula semelhante a flavivírus quimérico (vlp), flavivírus quimérico, e métodos in vitro para identificar um anticorpo neutralizante e para identificar uma composição imunogênica contra um vírus da dengue | |
| CO2018012099A2 (es) | Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos | |
| BR112015003093A8 (pt) | composições melhoradas de partículas substancialmente esféricas | |
| EA201490627A1 (ru) | Соединения для улучшенной вирусной трансдукции | |
| WO2013173512A3 (en) | High-transduction-efficiency raav vectors, compositions, and methods of use | |
| BR112013003823A2 (pt) | conjugados de peptídeo terapêutico-políemro, partículas, composições, e métodos relacionados | |
| MX2021013420A (es) | Composiciones utiles en el tratamiento de leucodistrofia metacromatica. | |
| EA202091712A1 (ru) | МОДИФИЦИРОВАННЫЙ КАПСИДНЫЙ БЕЛОК rAAV ДЛЯ ГЕННОЙ ТЕРАПИИ | |
| UY37863A (es) | Virus adenoasociado (aav) con dominio de fosfolipasa modificado | |
| MX2020011586A (es) | Virus vaccinia quimerico sintetico. | |
| BR112015026570A2 (pt) | composição antifadiga e uso da mesma | |
| CO2021016797A2 (es) | Composiciones de virus adenoasociadas para la transferencia del gen arsa y métodos de uso de las mismas | |
| MX2020004833A (es) | Un poliepitopo quimerico del virus del zika que comprende proteinas no estructurales y su uso en una composicion inmunogenica. | |
| BR112017024283A2 (pt) | vacinas contra a dengue |